David Adam

2.0k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

David Adam is a scholar working on Organic Chemistry, Molecular Biology and Physical and Theoretical Chemistry. According to data from OpenAlex, David Adam has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Physical and Theoretical Chemistry. Recurrent topics in David Adam's work include COVID-19 epidemiological studies (4 papers), Analytical Chemistry and Chromatography (3 papers) and Energetic Materials and Combustion (3 papers). David Adam is often cited by papers focused on COVID-19 epidemiological studies (4 papers), Analytical Chemistry and Chromatography (3 papers) and Energetic Materials and Combustion (3 papers). David Adam collaborates with scholars based in Canada, United Kingdom and Germany. David Adam's co-authors include E. Burkholder, Leroy Cronin, Paul Kögerler, Chris Ritchie, De‐Liang Long, G. Höll, Konstantin Karaghiosoff, Thomas M. Klapötke, Manfred Kaiser and G. A. Sim and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Analytical Chemistry.

In The Last Decade

David Adam

38 papers receiving 1.2k citations

Hit Papers

The pandemic’s true death toll: millions more than offici... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Adam Canada 12 274 273 153 144 116 43 1.2k
Yaning Wang China 13 224 0.8× 243 0.9× 55 0.4× 112 0.8× 35 0.3× 40 854
Luxi Zhang China 24 213 0.8× 72 0.3× 331 2.2× 622 4.3× 493 4.3× 95 2.6k
Thomas Douglas United Kingdom 23 32 0.1× 150 0.5× 121 0.8× 55 0.4× 270 2.3× 103 1.8k
Jie Yuan China 18 403 1.5× 140 0.5× 1.1k 7.4× 111 0.8× 94 0.8× 38 2.1k
Xuyu Chen China 14 134 0.5× 269 1.0× 36 0.2× 165 1.1× 179 1.5× 59 1.3k
Ran Li China 24 36 0.1× 161 0.6× 197 1.3× 29 0.2× 196 1.7× 95 1.8k
Minzhang Zheng United States 22 58 0.2× 61 0.2× 614 4.0× 98 0.7× 43 0.4× 66 2.3k
Bingjie Hu China 26 23 0.1× 584 2.1× 492 3.2× 325 2.3× 153 1.3× 79 2.1k
Qin Liu China 13 28 0.1× 131 0.5× 100 0.7× 52 0.4× 108 0.9× 36 620

Countries citing papers authored by David Adam

Since Specialization
Citations

This map shows the geographic impact of David Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Adam more than expected).

Fields of papers citing papers by David Adam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Adam. The network helps show where David Adam may publish in the future.

Co-authorship network of co-authors of David Adam

This figure shows the co-authorship network connecting the top 25 collaborators of David Adam. A scholar is included among the top collaborators of David Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Adam. David Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adam, David. (2024). Ketamine is in the spotlight thanks to Elon Musk — but is it the right treatment for depression?. Nature. 627(8005). 712–713. 1 indexed citations
2.
Adam, David. (2024). Misinformation might sway elections — but not in the way that you think. Nature. 630(8018). 807–809. 3 indexed citations
3.
Adam, David. (2023). “P factor” could open an important window on core attributes of mental health maladies. Proceedings of the National Academy of Sciences. 120(41). e2316297120–e2316297120.
4.
Adam, David, et al.. (2022). Coronapod: COVID death toll is likely millions more than official counts. Nature. 1 indexed citations
5.
Fineberg, Naomi, Luca Pellegrini, David Wellsted, et al.. (2021). Facing the “new normal”: How adjusting to the easing of COVID-19 lockdown restrictions exposes mental health inequalities. Journal of Psychiatric Research. 141. 276–286. 20 indexed citations
6.
Adam, David. (2020). Simulating the pandemic: What COVID forecasters can learn from climate models. Nature. 587(7835). 533–534. 7 indexed citations
7.
Adam, David. (2020). Special report: The simulations driving the world’s response to COVID-19. Nature. 580(7803). 316–318. 282 indexed citations
8.
Adam, David. (2008). Trouble ahead for dementia care. Nursing Older People. 20(6). 7–8. 1 indexed citations
9.
Ritchie, Chris, E. Burkholder, De‐Liang Long, et al.. (2007). Exploiting the multifunctionality of organocations in the assembly of hybrid polyoxometalate clusters and networks. Chemical Communications. 468–470. 63 indexed citations
10.
Adam, David. (2003). Out of the kitchen. Nature. 421(6923). 571–572. 262 indexed citations
11.
Adam, David. (2003). The times, they are a-changin'. Nature. 421(6920). 207–208. 3 indexed citations
12.
Adam, David, Konstantin Karaghiosoff, Thomas M. Klapötke, G. Höll, & Manfred Kaiser. (2002). Triazidotrinitro Benzene: 1,3,5-(N3)3-2,4,6-(NO2)3C6. Propellants Explosives Pyrotechnics. 27(1). 7–11. 28 indexed citations
13.
Adam, David. (2001). GlaxoSmithKline pushes its labs towards 'biotech' future. Nature. 410(6824). 5–5. 3 indexed citations
14.
Adam, David. (2001). Fears rise over BSE infection in UK abattoirs. Nature. 411(6839). 728–728. 3 indexed citations
15.
Adam, David, et al.. (1999). Nitrophenyl azides: A combined experimental and theoretical study. Heteroatom Chemistry. 10(7). 548–553. 10 indexed citations
16.
Scherowsky, G., et al.. (1997). 4,5,6,7,8,9-Hexamethoxyindeno[1,2,3-ij]isoquinoline. Acta Crystallographica Section C Crystal Structure Communications. 53(6). IUC9700005–IUC9700005. 3 indexed citations
17.
Cox, Philip, J.L. Wardell, David Adam, & Kenneth W. Muir. (1995). Crystal and molecular structure of triphenyl[2-(p-tolylthio)ethyl]tin. Journal of Chemical Crystallography. 25(8). 487–491. 1 indexed citations
18.
Adam, David, Andrew A. Freer, Neil W. Isaacs, et al.. (1992). Synthesis of a thiashikimic acid derivative. Journal of the Chemical Society Perkin Transactions 1. 1261–1261. 12 indexed citations
19.
Adam, David, et al.. (1971). Steroids and steroidases. 10. Potentially antitumor active androstane compounds containing C-17 nitrogen mustard functions. Journal of Medicinal Chemistry. 14(9). 827–833. 15 indexed citations
20.
Adam, David, et al.. (1969). A novel transformation of thiazolium salts to 2,3-dihydro-1,4-thiazines. Tetrahedron Letters. 10(36). 3063–3066. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026